Stamatina Cheilari is a PhD candidate in the School of Health Sciences at the University of East Anglia. She has a Master Degree in European Health Economics and Management and completed her thesis on “Pricing and reimbursement policies for Personalised Medicine with the example of oncology. Comparative analysis between the USA, Canada, the UK and France”.
Her doctorate degree is focused on glycated haemoglobin (HbA1c), a blood test currently used for the diagnosis of Type 2 Diabetes Mellitus and monitoring of glycaemia.
Currently she is involved in the following projects:
- The validity of HbA1c, as a measure of glycaemia in patients with chronic kidney disease and with or without anaemia.
- The utility of HbA1c test as a predictive marker of chronic kidney disease incidence and progression in patients with newly diagnosed non-diabetic hyperglycaemia or Type 2 Diabetes Mellitus.
- Does ethnicity/race affect the HbA1c test independently of glycaemia? A systematic review http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42017062130